ReviewAsia-Pacific journal of clinical oncology2026
Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia.
Andrew Redfern et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.